FLT3 and acute myeloid leukemia: Multivariable analysis showed that IPM-HR, older age, TP53 mutation, FLT3-ITD, and DNMT3A mutations were all independent adverse prognostic factors for OS in AML patients with intermediate and adverse-cytogenetic risk (Table 1).